The success of clinical adiponectin research started with the landmark publication by Arita and colleagues, where they first described that healthy volunteers demonstrate much higher serum concentrations compared to obese subjects, establishing the “adiponectin deficiency” in obesity [42]. Here, ADIPOQ is linked to hyperinsulinemic hypoglycemia, familial, 4.